IL156041A0 - Nucleic acid adjuvants - Google Patents

Nucleic acid adjuvants

Info

Publication number
IL156041A0
IL156041A0 IL15604101A IL15604101A IL156041A0 IL 156041 A0 IL156041 A0 IL 156041A0 IL 15604101 A IL15604101 A IL 15604101A IL 15604101 A IL15604101 A IL 15604101A IL 156041 A0 IL156041 A0 IL 156041A0
Authority
IL
Israel
Prior art keywords
nucleic acid
molecules
truncated
acid adjuvants
coding region
Prior art date
Application number
IL15604101A
Other languages
English (en)
Original Assignee
Powderject Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Powderject Vaccines Inc filed Critical Powderject Vaccines Inc
Publication of IL156041A0 publication Critical patent/IL156041A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15604101A 2000-11-27 2001-11-26 Nucleic acid adjuvants IL156041A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72431500A 2000-11-27 2000-11-27
PCT/US2001/043151 WO2003004055A2 (en) 2000-11-27 2001-11-26 Nucleic acid adjuvants

Publications (1)

Publication Number Publication Date
IL156041A0 true IL156041A0 (en) 2003-12-23

Family

ID=24909936

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15604101A IL156041A0 (en) 2000-11-27 2001-11-26 Nucleic acid adjuvants
IL156041A IL156041A (en) 2000-11-27 2003-05-21 An auxiliary drug preparation that includes nucleic acid sequences

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL156041A IL156041A (en) 2000-11-27 2003-05-21 An auxiliary drug preparation that includes nucleic acid sequences

Country Status (16)

Country Link
EP (1) EP1379273B1 (de)
JP (1) JP4221289B2 (de)
KR (1) KR20040045391A (de)
CN (1) CN1317034C (de)
AT (1) ATE442858T1 (de)
AU (1) AU2001297988B2 (de)
BR (1) BR0115646A (de)
CA (1) CA2429708A1 (de)
DE (1) DE60139959D1 (de)
DK (1) DK1379273T3 (de)
ES (1) ES2332261T3 (de)
IL (2) IL156041A0 (de)
MX (1) MXPA03004638A (de)
NZ (1) NZ526175A (de)
PT (1) PT1379273E (de)
WO (1) WO2003004055A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG147430A1 (en) 2003-10-10 2008-11-28 Powderject Vaccines Inc Nucleic acid constructs
WO2005077977A2 (en) 2004-02-11 2005-08-25 Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa Carcinoembryonic antigen fusions proteins and uses thereof
GB0507997D0 (en) * 2005-02-01 2005-05-25 Powderject Vaccines Inc Nucleic acid constructs
JP5311508B2 (ja) * 2008-05-07 2013-10-09 国立大学法人大阪大学 非共有結合型コラーゲン架橋剤
KR101881176B1 (ko) 2010-09-15 2018-07-23 랜달 제이 미스니 박테리아 독소에서 유래된 수송 서열을 이용한 생물활성제 시스템 및 방법
US11246915B2 (en) 2010-09-15 2022-02-15 Applied Molecular Transport Inc. Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
CN103060253A (zh) * 2013-01-24 2013-04-24 麻丽丹 霍乱弧菌ctxAB基因的质粒克隆菌株以及制备方法和应用
RU2723178C2 (ru) 2014-05-07 2020-06-09 ЭППЛАЙД МОЛЕКЬЮЛАР ТРАНСПОРТ ЭлЭлСи Слитые молекулы, происходящие от Cholix-токсина, для пероральной доставки биологически активных нагрузок
EP4082558B1 (de) 2018-03-08 2023-08-23 Applied Molecular Transport Inc. Von toxinen abgeleitete konstrukte zur oralen verabreichung
EP4083058A3 (de) 2018-11-07 2023-01-11 Applied Molecular Transport Inc. Verabreichungskonstrukte für die transzytose und zugehörige verfahren
TW202120521A (zh) 2019-08-16 2021-06-01 美商應用分子運輸公司 組合物、配方及介白素生產及純化

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5219740A (en) 1987-02-13 1993-06-15 Fred Hutchinson Cancer Research Center Retroviral gene transfer into diploid fibroblasts for gene therapy
TW404844B (en) 1993-04-08 2000-09-11 Oxford Biosciences Ltd Needleless syringe
GB9416663D0 (en) 1994-08-17 1994-10-12 Oxford Bioscience Limited Particle delivery
AU3703895A (en) 1994-10-24 1996-05-15 Oxford Biosciences Limited Particle delivery
GB9426379D0 (en) 1994-12-23 1995-03-01 Oxford Biosciences Ltd Particle delivery
US6056960A (en) * 1995-06-07 2000-05-02 Kaslow; Harvey R. Compositions exhibiting ADP-ribosyltransferase activity and methods for the preparation and use thereof
GB9612629D0 (en) 1996-06-17 1996-08-21 Oxford Biosciences Ltd Method for providing dense particle compositions for use in transdermal particle delivery
US5980898A (en) 1996-11-14 1999-11-09 The United States Of America As Represented By The U.S. Army Medical Research & Material Command Adjuvant for transcutaneous immunization

Also Published As

Publication number Publication date
KR20040045391A (ko) 2004-06-01
EP1379273A2 (de) 2004-01-14
ATE442858T1 (de) 2009-10-15
PT1379273E (pt) 2009-11-27
DK1379273T3 (da) 2009-11-09
JP4221289B2 (ja) 2009-02-12
CA2429708A1 (en) 2003-01-16
WO2003004055A2 (en) 2003-01-16
EP1379273B1 (de) 2009-09-16
CN1317034C (zh) 2007-05-23
CN1537013A (zh) 2004-10-13
IL156041A (en) 2010-05-17
DE60139959D1 (de) 2009-10-29
BR0115646A (pt) 2005-12-13
NZ526175A (en) 2006-01-27
MXPA03004638A (es) 2004-04-20
JP2004536107A (ja) 2004-12-02
ES2332261T3 (es) 2010-02-01
AU2001297988B2 (en) 2006-10-26
WO2003004055A3 (en) 2003-11-20

Similar Documents

Publication Publication Date Title
AU4078599A (en) Expression vectors for stimulating an immune response and methods of using the same
GB2347932B (en) Vectors for the delivery of 5T4 antigen
BR9906927A (pt) Proteìnas de neisseria meningitidis
BR0010361A (pt) Seq ências genÈmicas de neisseria e uso destas
PT100781A (pt) Sequencias de dna codificadoras de proteinas de superficie externa, proteinas contendo as referidas sequencias, obtidas a partir de borrelia burgdorferi, e vacinas contendo as referidas proteinas
NZ540544A (en) Nucleic acids and proteins from streptococcus groups A & B
PT1487485E (pt) Adjuvantes de imidazoquinolina para vacinas de adn
WO2001035991A3 (en) Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereof
EP1288299A3 (de) TRNA Synthetase
NZ532665A (en) Neisseria meningitidis antigens and compositions
EP1187591A4 (de) Mit entzündlichen darmerkrankungen (ibd) assoziierte mikrobielle antigene und verfahren derer anwendung
AU7235794A (en) Vaccine compositions
IL156041A0 (en) Nucleic acid adjuvants
WO2002062296A3 (en) Methods and compositions useful for stimulating an immune response
WO2003085085A3 (en) Superior molecular vaccine linking the translocation domain of a bacterial toxin to an antigen
AU8127494A (en) Chimeric proteins comprising borrelia polypeptides: uses therefor
DK1379550T3 (da) Et kimært protein omfattende non-toxisk pseudomonas exotoxin A og en type IV pilin sekvenser
MXPA01008605A (es) Proteina de enlace del antigeno goodpasture.
DK0811071T3 (da) Amplifikeringssekvenser hidrørende fra desmin-genet, vektorer indeholdende disse sekvenser og anvendelse heraf til fremstilling af proteiner
AU2001248822A1 (en) Gd3-mimetic peptides
EP0972054A4 (de) Steigerung der immunantwort unter verwendung von zielgerichteten molekülen
WO2000063385A3 (en) Nucleic acid immunization
HK1011924A1 (en) Monoclonal antibodies to antigens expressed by hematopoietic facilitaroy cells.
WO2000047227A3 (en) Mycobacterium tuberculosis, immunization
MXPA03010527A (es) Composicion de vacuna.